Clinical trial
A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)
NCT00127153 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00127153 |
|---|---|
| Title | A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) |
| Official title | A Comparative Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of V110 Formulated With Either All New Process Polysaccharides or All Current Process Polysaccharides |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy, Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | V110, pneumococcal vaccine polyvalent |
| Enrollment | 130 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Aug 5, 2005 |
| Last update posted | Jan 29, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: